Neurotech International (NTI) has launched an Authorised Prescriber program for NTI164 – a low-THC, broad-spectrum oral […]
Neurotech Opens Authorised Prescriber Pathway for Children's Cannabinoid Drug NTI164
The Cannabis Observer
·
FOUNDING MEMBERS
First 100 readers lock in 50% off for life
Sector coverage written for operators, not tourists. Reserve founding-member pricing before launch.
- Weekday briefings on regulation, access schemes, and the companies shaping the market
- Full archive and weekly deep-dives once premium goes live
- 50% off the launch price, locked in for as long as your subscription stays active
Join 87 readers already on the waitlist
Authorised Prescriber
autism
Dr Anthony Filippis
neurological
Neurotech
NTI164
Professor Michael Fahey
Related Articles
